Your browser doesn't support javascript.
loading
High treatment efficacy by dual targeting of Burkitt's lymphoma xenografted mice with a (177)Lu-based CD22-specific radioimmunoconjugate and rituximab.
Weber, Tobias; Bötticher, Benedikt; Mier, Walter; Sauter, Max; Krämer, Susanne; Leotta, Karin; Keller, Armin; Schlegelmilch, Anne; Grosse-Hovest, Ludger; Jäger, Dirk; Haberkorn, Uwe; Arndt, Michaela A E; Krauss, Jürgen.
Afiliación
  • Weber T; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Bötticher B; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Mier W; Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany.
  • Sauter M; Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany.
  • Krämer S; Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Leotta K; Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany.
  • Keller A; Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany.
  • Schlegelmilch A; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Grosse-Hovest L; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Jäger D; Department of Immunology, University of Tübingen, Tübingen, Germany.
  • Haberkorn U; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Arndt MA; Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany.
  • Krauss J; Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Eur J Nucl Med Mol Imaging ; 43(3): 489-98, 2016 Mar.
Article en En | MEDLINE | ID: mdl-26341366

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfoma de Burkitt / Radioinmunoterapia / Inmunoconjugados / Lectina 2 Similar a Ig de Unión al Ácido Siálico / Rituximab / Lutecio Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2016 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfoma de Burkitt / Radioinmunoterapia / Inmunoconjugados / Lectina 2 Similar a Ig de Unión al Ácido Siálico / Rituximab / Lutecio Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2016 Tipo del documento: Article País de afiliación: Alemania